Surgify develops new solutions to protect these structures and prevent associated complications. Bleeding, infections and nerve injuries.
Surgify has raised $7.9M in total funding. The most recent round was Series A. The last funding was announced in May 2025.
Surgify's investors include European Innovation Council, Innovestor, European Innovation Council Fund, Wave Ventures, Butterfly Ventures.
Surgify is headquartered in Espoo, Finland.
Surgify develops new solutions to protect these structures and prevent associated complications. Bleeding, infections and nerve injuries.
Surgify is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Surgify — Funding & Investors." VCBacked, May 27, 2025, https://www.vcbacked.co/company/surgify. Accessed September 7, 2026.
VCBacked. (2025). Surgify — Funding & Investors. Retrieved September 7, 2026, from https://www.vcbacked.co/company/surgify
{{cite web |title=Surgify — Funding & Investors |url=https://www.vcbacked.co/company/surgify |website=VCBacked |access-date=September 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated